| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Isoform of Protein Kinase C, Inhibits Promotional Phase in Mouse Skin Carcinogenesis1
Department of Cancer Cell Research, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-Ku, Tokyo 108, Japan
Cholesterol sulfate is a second messenger for the
isoform of protein kinase C mediating squamous differentiation. We found that cholesterol sulfate inhibited the promotional phase of skin carcinogenesis in female CD-1 mice, which was initiated by 100 µg 7,12-dimethylbenz[a]-anthracene and promoted by a single application of 10 µg 12-O-tetradecanoylphorbol-13-acetate, followed by repeated applications of 10 µg mezerein once a week for 19 weeks. Cholesterol sulfate, when applied topically at a dose of 400 µg (820 µmol) 10 min before treatment with the promoters, markedly suppressed tumor formation, resulting in decrease of 56% in the incidence of tumor-bearing mice, 81% in the number of tumors/mouse, and 60% in the size of tumors at 20 weeks of the promotion. This inhibition was not due to elimination of the initiated cells. Treatment with the parental cholesterol at a dose of 320 µg (820 µmol), which does not activate the
isoform, did not inhibit tumor promotion. Repeated treatment with cholesterol sulfate induced scaling of skin at the site of application. Cholesterol sulfate, unlike most inhibitors of tumor promotion, did not inhibit induction of ornithine decarboxylase and hyperplasia in mouse epidermis caused by topical treatment with 12-O-tetradecanoylphorbol-13-acetate. These findings suggest that cholesterol sulfate inhibits tumor promotion by stimulating a differentiation pathway mediated by the
isoform of protein kinase C.
1 This research was supported by a Grant-in-Aid for Special Project for Cancer Research from the Ministry of Education, Science and Culture of Japan.
2 To whom requests for reprints should be addressed, at Department of Cancer Cell Research, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-Ku, Tokyo 108, Japan. Phone: +81-3-5449-5255; Fax: +81-3-5449-5414.
Received 3/27/95. Accepted 8/25/95.
This article has been cited by other articles:
![]() |
K. Chida, T. Hara, T. Hirai, C. Konishi, K. Nakamura, K. Nakao, A. Aiba, M. Katsuki, and T. Kuroki Disruption of Protein Kinase C{eta} Results in Impairment of Wound Healing and Enhancement of Tumor Formation in Mouse Skin Carcinogenesis Cancer Res., May 15, 2003; 63(10): 2404 - 2408. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Nemes, M. Demeny, L. N. Marekov, L. Fesus, and P. M. Steinert Cholesterol 3-Sulfate Interferes with Cornified Envelope Assembly by Diverting Transglutaminase 1 Activity from the Formation of Cross-links and Esters to the Hydrolysis of Glutamine J. Biol. Chem., January 28, 2000; 275(4): 2636 - 2646. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ohba, K. Ishino, M. Kashiwagi, S. Kawabe, K. Chida, N.-H. Huh, and T. Kuroki Induction of Differentiation in Normal Human Keratinocytes by Adenovirus-Mediated Introduction of the eta and delta Isoforms of Protein Kinase C Mol. Cell. Biol., September 1, 1998; 18(9): 5199 - 5207. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |